CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.99 +0.19 (+3.96%)
As of: Oct 19, 2026 · 2:27 PM EDT

CNS Pharmaceuticals (CNSP) Revenue (2022 - 2024)

Updated

Analysis

CNS Pharmaceuticals (CNSP) Revenue (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn 25.31 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn 16.99 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn 15.03 Bn
10 CNS Pharmaceuticals 2.19 Mn -40.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 106.00
Dec 31, 2023 4,121.00
Sep 30, 2023 11,045.00
Jun 30, 2023 4,152.00
Mar 31, 2023 -5,436.00
Dec 31, 2022 -2,312.00
Sep 30, 2022 -538.00
Jun 30, 2022 -1,611.00
API Access

CNS Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CNSP&period=max&api_key=YOUR_API_KEY